The historical status of Viagra, and its parent firm copyright, presents a intriguing question for investors . While profits initially exploded , the approaching patent lapse and rising generic rivalry https://amberpeyt330159.imblogs.net/91369582/the-blue-pill-and-the-pharmaceutical-industry-a-uncertain-investment